Literature DB >> 19234694

Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

Christina Mueller-Mang1, Thomas Mang, Agnes Pirker, Katharina Klein, Christine Prchla, Daniela Prayer.   

Abstract

INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is a clinico-neuroradiological entity, characterized by typical neurological deficits, distinctive magnetic resonance imaging (MRI) features, and a usually benign clinical course. Although frequently seen in association with hypertensive conditions, many other predisposing factors, notably cytotoxic and immunosuppressant drugs have been associated with PRES. The aim of this study was to determine differences in the MR appearance of PRES according to various risk factors.
METHODS: Thirty consecutive patients with clinical and MRI findings consistent with PRES were included. We identified 24 patients with hypertension-related conditions, including 14 patients with preeclampsia-eclampsia, and six patients without hypertension, in whom PRES was associated with exposition to neurotoxic substances. Lesion distribution, extent of disease, and number of affected brain regions were compared between patients with PRES with and without hypertension, and patients with PRES with and without preeclampsia-eclampsia, respectively.
RESULTS: No statistically significant differences in distribution of lesions and extent of disease were observed between patients with PRES with or without hypertension, and patients with or without preeclampsia-eclampsia, respectively. The number of affected brain regions was significantly higher in patients with preeclampsia-eclampsia (p = 0.046), and the basal ganglia region was more frequently involved in these patients (p = 0.066).
CONCLUSION: Apart from a significant higher number of involved brain regions and a tendency for basal ganglia involvement in patients with PRES associated with preeclampsia-eclampsia, the MRI appearance of patients with PRES does not seem to be influenced by predisposing risk factors.

Entities:  

Mesh:

Year:  2009        PMID: 19234694     DOI: 10.1007/s00234-009-0504-0

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  37 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Cortical hyperintensity on proton density-weighted images: An MR sign of cyclosporine-related encephalopathy.

Authors:  O Jansen; D Krieger; S Krieger; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  1996-02       Impact factor: 3.825

3.  Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging.

Authors:  P Mukherjee; R C McKinstry
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

4.  Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression.

Authors:  C Horbinski; W S Bartynski; E Carson-Walter; R L Hamilton; H P Tan; S Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-14       Impact factor: 3.825

5.  Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.

Authors:  G M Rodgers; R N Taylor; J M Roberts
Journal:  Am J Obstet Gynecol       Date:  1988-10       Impact factor: 8.661

6.  The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance.

Authors:  A Benigni; M Morigi; N Perico; C Zoja; C S Amuchastegui; A Piccinelli; R Donadelli; G Remuzzi
Journal:  Transplantation       Date:  1992-11       Impact factor: 4.939

Review 7.  Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.

Authors:  Ashraf Badros; Olga Goloubeva; Jay S Dalal; Ilyas Can; Jennifer Thompson; Aaron P Rapoport; Meyer Heyman; Gorgon Akpek; Robert G Fenton
Journal:  Cancer       Date:  2007-09-01       Impact factor: 6.860

8.  Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain.

Authors:  Heike J Schoch; Silvia Fischer; Hugo H Marti
Journal:  Brain       Date:  2002-11       Impact factor: 13.501

9.  Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.

Authors:  Diego J Covarrubias; Patrick H Luetmer; Norbert G Campeau
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

10.  Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients.

Authors:  Giuseppe Servillo; Pasquale Striano; Salvatore Striano; Fabio Tortora; Patrizia Boccella; Edoardo De Robertis; Flavia Rossano; Francesco Briganti; Rosalba Tufano
Journal:  Intensive Care Med       Date:  2003-08-06       Impact factor: 17.440

View more
  42 in total

1.  Cortical blindness and posterior reversible encephalopathy syndrome in an older patient.

Authors:  Sabrina Ait; Thomas Gilbert; Francois Cotton; Marc Bonnefoy
Journal:  BMJ Case Rep       Date:  2012-05-26

2.  Posterior reversible encephalopathy syndrome in pregnancy: a retrospective series of 36 patients from mainland China.

Authors:  Y Wen; B Yang; Q Huang; Y Liu
Journal:  Ir J Med Sci       Date:  2017-02-02       Impact factor: 1.568

Review 3.  [Demyelinating disorders].

Authors:  T Weber; W Köhler
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

4.  Type of edema in posterior reversible encephalopathy syndrome depends on serum albumin levels: an MR imaging study in 28 patients.

Authors:  A Pirker; L Kramer; B Voller; B Loader; E Auff; D Prayer
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-20       Impact factor: 3.825

Review 5.  Imaging neurological emergencies in pregnancy and puerperium.

Authors:  Matthew A Haber; Diego Nunez
Journal:  Emerg Radiol       Date:  2018-07-20

6.  Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.

Authors:  Samuel Singer; Christian Grommes; Anne S Reiner; Marc K Rosenblum; Lisa M DeAngelis
Journal:  Oncologist       Date:  2015-06-01

7.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

Authors:  Jennifer E Fugate; Daniel O Claassen; Harry J Cloft; David F Kallmes; Osman S Kozak; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

8.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

Review 9.  Preeclampsia: Association With Posterior Reversible Encephalopathy Syndrome and Stroke.

Authors:  Mollie McDermott; Eliza C Miller; Tatjana Rundek; Patricia D Hurn; Cheryl D Bushnell
Journal:  Stroke       Date:  2018-02-08       Impact factor: 7.914

10.  Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome.

Authors:  Aseem Sharma; Ryan T Whitesell; Kelsey J Moran
Journal:  Neuroradiology       Date:  2009-12-03       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.